Publications
5532 Results
- Journal / Conference
- AJCO 17(2):173-180
- Year
- 1994
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8811
Phase II trial of 5-fluorouracil and high-dose folinic acid as first or second-line therapy for advanced breast cancer.
- Journal / Conference
- Journal of Clinical Oncology 12(9):1814-1820
- Year
- 1994
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8836
Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small cell lung cancer: Results of phase II Southwest Oncology Group study.
- Journal / Conference
- Cancer Chemotherapy and Pharmacology 33:340-346
- Year
- 1994
- Research Committee(s)
- Developmental Biologics
- Study Number(s)
- SWOG-8902
GM-CSF, carboplatin, doxorubicin: a phase I study
- Journal / Conference
- Investigational New Drugs 12:53-55
- Year
- 1994
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8944
Phase II study of carboplatin (CBDCA) in refractory multiple myeloma: A Southwest Oncology Group study.
- Journal / Conference
- Cancer 74(3):1135-1138
- Year
- 1994
Current trials and future directions of the Southwest Oncology Group (SWOG) Breast Cancer Committee.
- Journal / Conference
- Journal of the National Cancer Institute Monographs 16:35-42
- Year
- 1994
Breast cancer outcome and predictors of outcome: Are there age differentials?
- Journal / Conference
- Lung Cancer 11(Suppl.1):102(#389)
- Year
- 1994
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8609
SWOG 8609 - a phase II trial of teniposide (VM-26) as therapy for extensive small cell lung cancer (SCLC)
- Journal / Conference
- Cancer 73(5):1505-1508
- Year
- 1994
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8411
Phase II trial of dimethyl triazeno imidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study.
- Journal / Conference
- Cancer Chemotherapy and Pharmacology 34(2):179-180
- Year
- 1994
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-8834
A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study
- Journal / Conference
- Cancer 74(3):916-919
- Year
- 1994
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8926